BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 17413016)

  • 1. Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease.
    de Leon MJ; Mosconi L; Blennow K; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Tsui W; Saint Louis LA; Sobanska L; Brys M; Li Y; Rich K; Rinne J; Rusinek H
    Ann N Y Acad Sci; 2007 Feb; 1097():114-45. PubMed ID: 17413016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional MRI studies of associative encoding in normal aging, mild cognitive impairment, and Alzheimer's disease.
    Sperling R
    Ann N Y Acad Sci; 2007 Feb; 1097():146-55. PubMed ID: 17413017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.
    Mosconi L
    Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):486-510. PubMed ID: 15747152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linking brain imaging and genomics in the study of Alzheimer's disease and aging.
    Reiman EM
    Ann N Y Acad Sci; 2007 Feb; 1097():94-113. PubMed ID: 17413015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of CSF and MRI biomarkers for detecting preclinical Alzheimer's disease.
    Schmand B; Huizenga HM; van Gool WA
    Psychol Med; 2010 Jan; 40(1):135-45. PubMed ID: 19863841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis.
    Mosconi L; Tsui WH; De Santi S; Li J; Rusinek H; Convit A; Li Y; Boppana M; de Leon MJ
    Neurology; 2005 Jun; 64(11):1860-7. PubMed ID: 15955934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection of Alzheimer's disease using neuroimaging.
    Mosconi L; Brys M; Glodzik-Sobanska L; De Santi S; Rusinek H; de Leon MJ
    Exp Gerontol; 2007; 42(1-2):129-38. PubMed ID: 16839732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal classification of Alzheimer's disease and mild cognitive impairment.
    Zhang D; Wang Y; Zhou L; Yuan H; Shen D;
    Neuroimage; 2011 Apr; 55(3):856-67. PubMed ID: 21236349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers.
    Shaffer JL; Petrella JR; Sheldon FC; Choudhury KR; Calhoun VD; Coleman RE; Doraiswamy PM;
    Radiology; 2013 Feb; 266(2):583-91. PubMed ID: 23232293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer's disease.
    Reinvang I; Espeseth T; Westlye LT
    Neurosci Biobehav Rev; 2013 Sep; 37(8):1322-35. PubMed ID: 23701948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrimination of normal aging, MCI and AD with multimodal imaging measures on the medial temporal lobe.
    Jhoo JH; Lee DY; Choo IH; Seo EH; Oh JS; Lee JS; Lee DS; Kim SG; Youn JC; Kim KW; Woo JI
    Psychiatry Res; 2010 Sep; 183(3):237-43. PubMed ID: 20705437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD.
    Jack CR; Shiung MM; Gunter JL; O'Brien PC; Weigand SD; Knopman DS; Boeve BF; Ivnik RJ; Smith GE; Cha RH; Tangalos EG; Petersen RC
    Neurology; 2004 Feb; 62(4):591-600. PubMed ID: 14981176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline.
    Lista S; Molinuevo JL; Cavedo E; Rami L; Amouyel P; Teipel SJ; Garaci F; Toschi N; Habert MO; Blennow K; Zetterberg H; O'Bryant SE; Johnson L; Galluzzi S; Bokde AL; Broich K; Herholz K; Bakardjian H; Dubois B; Jessen F; Carrillo MC; Aisen PS; Hampel H
    J Alzheimers Dis; 2015 Sep; 48 Suppl 1():S171-91. PubMed ID: 26402088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.
    Blasko I; Jellinger K; Kemmler G; Krampla W; Jungwirth S; Wichart I; Tragl KH; Fischer P
    Neurobiol Aging; 2008 Jan; 29(1):1-11. PubMed ID: 17055615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relation of regional cerebral perfusion and atrophy in mild cognitive impairment (MCI) and early Alzheimer's dementia.
    Luckhaus C; Cohnen M; Flüss MO; Jänner M; Grass-Kapanke B; Teipel SJ; Grothe M; Hampel H; Peters O; Kornhuber J; Maier W; Supprian T; Gaebel W; Mödder U; Wittsack HJ
    Psychiatry Res; 2010 Jul; 183(1):44-51. PubMed ID: 20541374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers in Swedish familial Alzheimer's disease.
    Thordardottir S; Ståhlbom AK; Ferreira D; Almkvist O; Westman E; Zetterberg H; Eriksdotter M; Blennow K; Graff C
    J Alzheimers Dis; 2015; 43(4):1393-402. PubMed ID: 25182737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET).
    de Leon MJ; Convit A; Wolf OT; Tarshish CY; DeSanti S; Rusinek H; Tsui W; Kandil E; Scherer AJ; Roche A; Imossi A; Thorn E; Bobinski M; Caraos C; Lesbre P; Schlyer D; Poirier J; Reisberg B; Fowler J
    Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10966-71. PubMed ID: 11526211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.